129 related articles for article (PubMed ID: 8796366)
1. Bone alkaline phosphatase measured with a new immunoradiometric assay in patients with metabolic bone diseases.
Gonnelli S; Cepollaro C; Montagnani A; Monaci G; Campagna MS; Franci MB; Gennari C
Eur J Clin Invest; 1996 May; 26(5):391-6. PubMed ID: 8796366
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
Garnero P; Delmas PD
J Clin Endocrinol Metab; 1993 Oct; 77(4):1046-53. PubMed ID: 8104954
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases.
Braga V; Dorizzi R; Brocco G; Rossini M; Zamberlan N; Gatti D; Adami S
Eur J Clin Chem Clin Biochem; 1995 Jul; 33(7):433-9. PubMed ID: 7548450
[TBL] [Abstract][Full Text] [Related]
4. Comparison of bone and total alkaline phosphatase activity on bone turnover during menopause and in patients with established osteoporosis.
Takahashi M; Kushida K; Hoshino H; Miura M; Ohishi T; Inoue T
Clin Endocrinol (Oxf); 1997 Aug; 47(2):177-83. PubMed ID: 9302392
[TBL] [Abstract][Full Text] [Related]
5. Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients.
Kushida K; Takahashi M; Kawana K; Inoue T
J Clin Endocrinol Metab; 1995 Aug; 80(8):2447-50. PubMed ID: 7629240
[TBL] [Abstract][Full Text] [Related]
6. Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase.
Broyles DL; Nielsen RG; Bussett EM; Lu WD; Mizrahi IA; Nunnelly PA; Ngo TA; Noell J; Christenson RH; Kress BC
Clin Chem; 1998 Oct; 44(10):2139-47. PubMed ID: 9761247
[TBL] [Abstract][Full Text] [Related]
7. Elevation of serum alkaline phosphatase (ALP) level in postmenopausal women is caused by high bone turnover.
Mukaiyama K; Kamimura M; Uchiyama S; Ikegami S; Nakamura Y; Kato H
Aging Clin Exp Res; 2015 Aug; 27(4):413-8. PubMed ID: 25534961
[TBL] [Abstract][Full Text] [Related]
8. Lack of correlation between levels of osteocalcin and bone alkaline phosphatase in healthy control and postmenopausal osteoporotic women.
Díaz Diego EM; Díaz Martín MA; de la Piedra C; Rapado A
Horm Metab Res; 1995 Mar; 27(3):151-4. PubMed ID: 7607606
[TBL] [Abstract][Full Text] [Related]
9. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
Verit FF; Geyikli I; Yazgan P; Celik A
Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.
Guo CY; Weetman AP; Eastell R
Clin Endocrinol (Oxf); 1997 Mar; 46(3):301-7. PubMed ID: 9156039
[TBL] [Abstract][Full Text] [Related]
11. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
12. Relationship of bone turnover parameters, endogenous hormones and vit D deficiency to hip fracture in elderly postmenopausal women.
Erem C; Tanakol R; Alagöl F; Omer B; Cetin O
Int J Clin Pract; 2002 Jun; 56(5):333-7. PubMed ID: 12137439
[TBL] [Abstract][Full Text] [Related]
13. Osteocalcin and bone-specific alkaline phosphatase in sickle cell haemoglobinopathies.
Azinge EC; Bolarin DM
Niger J Physiol Sci; 2006; 21(1-2):21-5. PubMed ID: 17242729
[TBL] [Abstract][Full Text] [Related]
14. The effect of menopause and hormone replacement therapy on bone alkaline phosphatase.
Alexandersen P; Hassager C; Riis BJ
Scand J Clin Lab Invest; 1995 Nov; 55(7):571-6. PubMed ID: 8633181
[TBL] [Abstract][Full Text] [Related]
15. Two bone alkaline phosphatase assays compared with osteocalcin as a marker of bone formation in healthy elderly women.
Bouman AA; Scheffer PG; Ooms ME; Lips P; Netelenbos C
Clin Chem; 1995 Feb; 41(2):196-9. PubMed ID: 7874771
[TBL] [Abstract][Full Text] [Related]
16. Clinical observations with a new specific assay for bone alkaline phosphatase: a cross-sectional study in osteoporotic and pagetic subjects and a longitudinal evaluation of the response to ovariectomy, estrogens, and bisphosphonates.
Pedrazzoni M; Alfano FS; Girasole G; Giuliani N; Fantuzzi M; Gatti C; Campanini C; Passeri M
Calcif Tissue Int; 1996 Nov; 59(5):334-8. PubMed ID: 8849398
[TBL] [Abstract][Full Text] [Related]
17. [Biochemical markers of bone formation in osteoporosis].
Miki T; Nakatsuka K; Kawakami H; Kosaka H; Nishizawa Y; Morii H
Rinsho Byori; 1996 May; 44(5):410-4. PubMed ID: 8676558
[TBL] [Abstract][Full Text] [Related]
18. Relationship between dental panoramic radiographic findings and biochemical markers of bone turnover.
Taguchi A; Sanada M; Krall E; Nakamoto T; Ohtsuka M; Suei Y; Tanimoto K; Kodama I; Tsuda M; Ohama K
J Bone Miner Res; 2003 Sep; 18(9):1689-94. PubMed ID: 12968679
[TBL] [Abstract][Full Text] [Related]
19. Use of bone alkaline phosphatase to monitor alendronate therapy in individual postmenopausal osteoporotic women.
Kress BC; Mizrahi IA; Armour KW; Marcus R; Emkey RD; Santora AC
Clin Chem; 1999 Jul; 45(7):1009-17. PubMed ID: 10388477
[TBL] [Abstract][Full Text] [Related]
20. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.
Botella S; Restituto P; Monreal I; Colina I; Calleja A; Varo N
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
